698 related articles for article (PubMed ID: 20473790)
1. VZV T cell-mediated immunity.
Weinberg A; Levin MJ
Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
[TBL] [Abstract][Full Text] [Related]
2. Perspectives on vaccines against varicella-zoster virus infections.
Gershon AA; Gershon MD
Curr Top Microbiol Immunol; 2010; 342():359-72. PubMed ID: 20232192
[TBL] [Abstract][Full Text] [Related]
3. Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.
Meyer C; Engelmann F; Arnold N; Krah DL; ter Meulen J; Haberthur K; Dewane J; Messaoudi I
J Virol; 2015 Feb; 89(3):1781-93. PubMed ID: 25410871
[TBL] [Abstract][Full Text] [Related]
4. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
[TBL] [Abstract][Full Text] [Related]
5. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
[TBL] [Abstract][Full Text] [Related]
6. Immune evasion as a pathogenic mechanism of varicella zoster virus.
Abendroth A; Arvin AM
Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
[TBL] [Abstract][Full Text] [Related]
7. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.
Amlie-Lefond C; Gilden D
J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1561-1569. PubMed ID: 27138380
[TBL] [Abstract][Full Text] [Related]
8. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.
Schub D; Janssen E; Leyking S; Sester U; Assmann G; Hennes P; Smola S; Vogt T; Rohrer T; Sester M; Schmidt T
J Infect Dis; 2015 Feb; 211(4):600-12. PubMed ID: 25180236
[TBL] [Abstract][Full Text] [Related]
9. Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients.
Prelog M; Schönlaub J; Jeller V; Almanzar G; Höfner K; Gruber S; Eiwegger T; Würzner R
Vaccine; 2013 May; 31(20):2420-6. PubMed ID: 23583889
[TBL] [Abstract][Full Text] [Related]
10. CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.
Haberthur K; Engelmann F; Park B; Barron A; Legasse A; Dewane J; Fischer M; Kerns A; Brown M; Messaoudi I
PLoS Pathog; 2011 Nov; 7(11):e1002367. PubMed ID: 22102814
[TBL] [Abstract][Full Text] [Related]
11. Advances in the treatment of varicella-zoster virus infections.
Andrei G; Snoeck R
Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
[TBL] [Abstract][Full Text] [Related]
12. Review: The neurobiology of varicella zoster virus infection.
Gilden D; Mahalingam R; Nagel MA; Pugazhenthi S; Cohrs RJ
Neuropathol Appl Neurobiol; 2011 Aug; 37(5):441-63. PubMed ID: 21342215
[TBL] [Abstract][Full Text] [Related]
13. Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.
Eberhardt CS; Wieland A; Nasti TH; Grifoni A; Wilson E; Schmid DS; Pulendran B; Sette A; Waller EK; Rouphael N; Ahmed R
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321817
[TBL] [Abstract][Full Text] [Related]
14. Immune senescence and vaccines to prevent herpes zoster in older persons.
Levin MJ
Curr Opin Immunol; 2012 Aug; 24(4):494-500. PubMed ID: 22857823
[TBL] [Abstract][Full Text] [Related]
15. Cell-mediated immunity to varicella-zoster virus.
Arvin AM
J Infect Dis; 1992 Aug; 166 Suppl 1():S35-41. PubMed ID: 1320649
[TBL] [Abstract][Full Text] [Related]
16. Varicella zoster vaccines and their implications for development of HSV vaccines.
Gershon AA
Virology; 2013 Jan; 435(1):29-36. PubMed ID: 23217613
[TBL] [Abstract][Full Text] [Related]
17. Emerging drugs for varicella-zoster virus infections.
Andrei G; Snoeck R
Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
[TBL] [Abstract][Full Text] [Related]
18. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus.
Barbosa CM; Terreri MT; Rosário PO; de Moraes-Pinto MI; Silva CA; Hilário MO
Clin Exp Rheumatol; 2012; 30(5):791-8. PubMed ID: 22935227
[TBL] [Abstract][Full Text] [Related]
19. Molecular studies of the Oka varicella vaccine.
Quinlivan M; Breuer J; Schmid DS
Expert Rev Vaccines; 2011 Sep; 10(9):1321-36. PubMed ID: 21919621
[TBL] [Abstract][Full Text] [Related]
20. Increased incidence of herpes zoster in patients on renal replacement therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster virus.
Rondaan C; de Joode AAE; van Assen S; Bos NA; Westerhuis R; Westra J
Antiviral Res; 2018 Oct; 158():206-212. PubMed ID: 30102958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]